Successful completion of TRANSBIO clinical study
Biohope, an R&D company dedicated to the development of precision medicine IVD tools for chronic inflammatory conditions, announces the completion of the TRANSBIO clinical study. The TRANSBIO clinical [...]
Biohope at BIO International Convention
Ricardo Brage (Business Development Director) and Francisco Tejera (Financial Director) are in Philadelphia representing Biohope in this important convention that this year is celebrated in Philadelphia. [...]
Biohope Poster awarded at 2019 ATC
Our CEO Isabel Portero and medical director Teresa Díez are at ATC2019Boston presenting the results of BH-Pilot clinical study which demonstrate the use of Immunobiogram® in the personalization of immunos [...]
Interview with Isabel Portero in Radio.
Isabel Portero was invited to the radio program "Más y Mejor" of Radio Intereconomía on the occasion of the V Congress of scientific entrepreneurs. She talked about the important role of Spanish Biomedici [...]
Biohope invited to the Technical Investment Conference in Paris
The global objective of this conference is the promotion of Spanish biotechnology in France, as a potential destination for specialized investment in this sector by French investors. It also aims to stre [...]
Isabel Portero invited to the European Commission Investor Day
Isabel Portero, CEO of Biohope, participates in this invitation-only event organized by The European Innovation Council (EIC). EIC supports top-class innovators, entrepreneurs, small companies and scien [...]